Table S5 from A Prospective Study Exploring the Safety and Efficacy of Lenvatinib for Patients with Advanced Hepatocellular Carcinoma and High Tumor Burden: The LAUNCH Study Article Swipe
Kazufumi Kobayashi
,
Sadahisa Ogasawara
,
Susumu Maruta
,
Tomomi Okubo
,
Norio Itokawa
,
Yuki Haga
,
Yuya Seko
,
Michihisa Moriguchi
,
Shunji Watanabe
,
Yuki Shiko
,
Hirokazu Takatsuka
,
Hiroaki Kanzaki
,
Keisuke Koroki
,
Masanori Inoue
,
Masato Nakamura
,
Soichiro Kiyono
,
Naoya Kanogawa
,
Takayuki Kondo
,
Eiichiro Suzuki
,
Yoshihiko Ooka
,
Shingo Nakamoto
,
Yosuke Inaba
,
Masafumi Ikeda
,
Shinichiro Okabe
,
Naoki Morimoto
,
Yoshito Itoh
,
Kazuyoshi Nakamura
,
Kenji Ito
,
Ryosaku Azemoto
,
Masanori Atsukawa
,
Ei Itobayashi
,
Naoya Kato
·
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1158/1078-0432.24710897.v1
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1158/1078-0432.24710897.v1
Radiological assessments according to both mRECIST and RECIST 1.1 (evaluation by central review)
Related Topics
Concepts
Metadata
- Type
- preprint
- Language
- en
- Landing Page
- https://doi.org/10.1158/1078-0432.24710897.v1
- OA Status
- gold
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4389238576
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4389238576Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1158/1078-0432.24710897.v1Digital Object Identifier
- Title
-
Table S5 from A Prospective Study Exploring the Safety and Efficacy of Lenvatinib for Patients with Advanced Hepatocellular Carcinoma and High Tumor Burden: The LAUNCH StudyWork title
- Type
-
preprintOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2023Year of publication
- Publication date
-
2023-12-01Full publication date if available
- Authors
-
Kazufumi Kobayashi, Sadahisa Ogasawara, Susumu Maruta, Tomomi Okubo, Norio Itokawa, Yuki Haga, Yuya Seko, Michihisa Moriguchi, Shunji Watanabe, Yuki Shiko, Hirokazu Takatsuka, Hiroaki Kanzaki, Keisuke Koroki, Masanori Inoue, Masato Nakamura, Soichiro Kiyono, Naoya Kanogawa, Takayuki Kondo, Eiichiro Suzuki, Yoshihiko Ooka, Shingo Nakamoto, Yosuke Inaba, Masafumi Ikeda, Shinichiro Okabe, Naoki Morimoto, Yoshito Itoh, Kazuyoshi Nakamura, Kenji Ito, Ryosaku Azemoto, Masanori Atsukawa, Ei Itobayashi, Naoya KatoList of authors in order
- Landing page
-
https://doi.org/10.1158/1078-0432.24710897.v1Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1158/1078-0432.24710897.v1Direct OA link when available
- Concepts
-
Lenvatinib, Hepatocellular carcinoma, Medicine, Oncology, Expanded access, Radiological weapon, Internal medicine, Sorafenib, RadiologyTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4389238576 |
|---|---|
| doi | https://doi.org/10.1158/1078-0432.24710897.v1 |
| ids.doi | https://doi.org/10.1158/1078-0432.24710897.v1 |
| ids.openalex | https://openalex.org/W4389238576 |
| fwci | 0.0 |
| type | preprint |
| title | Table S5 from A Prospective Study Exploring the Safety and Efficacy of Lenvatinib for Patients with Advanced Hepatocellular Carcinoma and High Tumor Burden: The LAUNCH Study |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T10073 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.996999979019165 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2721 |
| topics[0].subfield.display_name | Hepatology |
| topics[0].display_name | Hepatocellular Carcinoma Treatment and Prognosis |
| topics[1].id | https://openalex.org/T10231 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.994700014591217 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2730 |
| topics[1].subfield.display_name | Oncology |
| topics[1].display_name | Pancreatic and Hepatic Oncology Research |
| topics[2].id | https://openalex.org/T12422 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9894999861717224 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2741 |
| topics[2].subfield.display_name | Radiology, Nuclear Medicine and Imaging |
| topics[2].display_name | Radiomics and Machine Learning in Medical Imaging |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2776264508 |
| concepts[0].level | 4 |
| concepts[0].score | 0.9887351989746094 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q6523413 |
| concepts[0].display_name | Lenvatinib |
| concepts[1].id | https://openalex.org/C2778019345 |
| concepts[1].level | 2 |
| concepts[1].score | 0.8664188981056213 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q1148337 |
| concepts[1].display_name | Hepatocellular carcinoma |
| concepts[2].id | https://openalex.org/C71924100 |
| concepts[2].level | 0 |
| concepts[2].score | 0.6294781565666199 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[2].display_name | Medicine |
| concepts[3].id | https://openalex.org/C143998085 |
| concepts[3].level | 1 |
| concepts[3].score | 0.5253807306289673 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q162555 |
| concepts[3].display_name | Oncology |
| concepts[4].id | https://openalex.org/C2775832928 |
| concepts[4].level | 2 |
| concepts[4].score | 0.48577645421028137 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q407954 |
| concepts[4].display_name | Expanded access |
| concepts[5].id | https://openalex.org/C190892606 |
| concepts[5].level | 2 |
| concepts[5].score | 0.45057258009910583 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q3512464 |
| concepts[5].display_name | Radiological weapon |
| concepts[6].id | https://openalex.org/C126322002 |
| concepts[6].level | 1 |
| concepts[6].score | 0.3763200342655182 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[6].display_name | Internal medicine |
| concepts[7].id | https://openalex.org/C2778695046 |
| concepts[7].level | 3 |
| concepts[7].score | 0.28325894474983215 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q421136 |
| concepts[7].display_name | Sorafenib |
| concepts[8].id | https://openalex.org/C126838900 |
| concepts[8].level | 1 |
| concepts[8].score | 0.2337726652622223 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q77604 |
| concepts[8].display_name | Radiology |
| keywords[0].id | https://openalex.org/keywords/lenvatinib |
| keywords[0].score | 0.9887351989746094 |
| keywords[0].display_name | Lenvatinib |
| keywords[1].id | https://openalex.org/keywords/hepatocellular-carcinoma |
| keywords[1].score | 0.8664188981056213 |
| keywords[1].display_name | Hepatocellular carcinoma |
| keywords[2].id | https://openalex.org/keywords/medicine |
| keywords[2].score | 0.6294781565666199 |
| keywords[2].display_name | Medicine |
| keywords[3].id | https://openalex.org/keywords/oncology |
| keywords[3].score | 0.5253807306289673 |
| keywords[3].display_name | Oncology |
| keywords[4].id | https://openalex.org/keywords/expanded-access |
| keywords[4].score | 0.48577645421028137 |
| keywords[4].display_name | Expanded access |
| keywords[5].id | https://openalex.org/keywords/radiological-weapon |
| keywords[5].score | 0.45057258009910583 |
| keywords[5].display_name | Radiological weapon |
| keywords[6].id | https://openalex.org/keywords/internal-medicine |
| keywords[6].score | 0.3763200342655182 |
| keywords[6].display_name | Internal medicine |
| keywords[7].id | https://openalex.org/keywords/sorafenib |
| keywords[7].score | 0.28325894474983215 |
| keywords[7].display_name | Sorafenib |
| keywords[8].id | https://openalex.org/keywords/radiology |
| keywords[8].score | 0.2337726652622223 |
| keywords[8].display_name | Radiology |
| language | en |
| locations[0].id | doi:10.1158/1078-0432.24710897.v1 |
| locations[0].is_oa | True |
| locations[0].source | |
| locations[0].license | cc-by |
| locations[0].pdf_url | |
| locations[0].version | acceptedVersion |
| locations[0].raw_type | posted-content |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | False |
| locations[0].raw_source_name | |
| locations[0].landing_page_url | https://doi.org/10.1158/1078-0432.24710897.v1 |
| locations[1].id | pmh:oai:figshare.com:article/24710897 |
| locations[1].is_oa | True |
| locations[1].source.id | https://openalex.org/S4306400572 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | OPAL (Open@LaTrobe) (La Trobe University) |
| locations[1].source.host_organization | https://openalex.org/I196829312 |
| locations[1].source.host_organization_name | La Trobe University |
| locations[1].source.host_organization_lineage | https://openalex.org/I196829312 |
| locations[1].license | cc-by |
| locations[1].pdf_url | |
| locations[1].version | submittedVersion |
| locations[1].raw_type | Text |
| locations[1].license_id | https://openalex.org/licenses/cc-by |
| locations[1].is_accepted | False |
| locations[1].is_published | False |
| locations[1].raw_source_name | |
| locations[1].landing_page_url | https://figshare.com/articles/journal_contribution/Table_S5_from_A_Prospective_Study_Exploring_the_Safety_and_Efficacy_of_Lenvatinib_for_Patients_with_Advanced_Hepatocellular_Carcinoma_and_High_Tumor_Burden_The_LAUNCH_Study/24710897 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5045756401 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-2604-7208 |
| authorships[0].author.display_name | Kazufumi Kobayashi |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Kazufumi Kobayashi |
| authorships[0].is_corresponding | False |
| authorships[1].author.id | https://openalex.org/A5101890457 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-6540-9064 |
| authorships[1].author.display_name | Sadahisa Ogasawara |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Sadahisa Ogasawara |
| authorships[1].is_corresponding | False |
| authorships[2].author.id | https://openalex.org/A5049821512 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | Susumu Maruta |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Susumu Maruta |
| authorships[2].is_corresponding | False |
| authorships[3].author.id | https://openalex.org/A5049568375 |
| authorships[3].author.orcid | https://orcid.org/0000-0003-1244-4736 |
| authorships[3].author.display_name | Tomomi Okubo |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Tomomi Okubo |
| authorships[3].is_corresponding | False |
| authorships[4].author.id | https://openalex.org/A5009103376 |
| authorships[4].author.orcid | https://orcid.org/0009-0002-2390-6692 |
| authorships[4].author.display_name | Norio Itokawa |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Norio Itokawa |
| authorships[4].is_corresponding | False |
| authorships[5].author.id | https://openalex.org/A5060263711 |
| authorships[5].author.orcid | https://orcid.org/0000-0002-0070-2091 |
| authorships[5].author.display_name | Yuki Haga |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Yuki Haga |
| authorships[5].is_corresponding | False |
| authorships[6].author.id | https://openalex.org/A5069773803 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-3658-5894 |
| authorships[6].author.display_name | Yuya Seko |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Yuya Seko |
| authorships[6].is_corresponding | False |
| authorships[7].author.id | https://openalex.org/A5004973697 |
| authorships[7].author.orcid | https://orcid.org/0000-0001-9779-4369 |
| authorships[7].author.display_name | Michihisa Moriguchi |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Michihisa Moriguchi |
| authorships[7].is_corresponding | False |
| authorships[8].author.id | https://openalex.org/A5054644272 |
| authorships[8].author.orcid | https://orcid.org/0000-0002-5449-6553 |
| authorships[8].author.display_name | Shunji Watanabe |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Shunji Watanabe |
| authorships[8].is_corresponding | False |
| authorships[9].author.id | https://openalex.org/A5074115820 |
| authorships[9].author.orcid | https://orcid.org/0000-0002-3959-9343 |
| authorships[9].author.display_name | Yuki Shiko |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Yuki Shiko |
| authorships[9].is_corresponding | False |
| authorships[10].author.id | https://openalex.org/A5050047021 |
| authorships[10].author.orcid | https://orcid.org/0000-0003-4374-3552 |
| authorships[10].author.display_name | Hirokazu Takatsuka |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Hirokazu Takatsuka |
| authorships[10].is_corresponding | False |
| authorships[11].author.id | https://openalex.org/A5016927438 |
| authorships[11].author.orcid | https://orcid.org/0000-0002-5039-9166 |
| authorships[11].author.display_name | Hiroaki Kanzaki |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Hiroaki Kanzaki |
| authorships[11].is_corresponding | False |
| authorships[12].author.id | https://openalex.org/A5066017229 |
| authorships[12].author.orcid | https://orcid.org/0000-0002-2345-2611 |
| authorships[12].author.display_name | Keisuke Koroki |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Keisuke Koroki |
| authorships[12].is_corresponding | False |
| authorships[13].author.id | https://openalex.org/A5050183765 |
| authorships[13].author.orcid | https://orcid.org/0009-0009-0938-7452 |
| authorships[13].author.display_name | Masanori Inoue |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Masanori Inoue |
| authorships[13].is_corresponding | False |
| authorships[14].author.id | https://openalex.org/A5001002762 |
| authorships[14].author.orcid | https://orcid.org/0000-0003-4080-2967 |
| authorships[14].author.display_name | Masato Nakamura |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | Masato Nakamura |
| authorships[14].is_corresponding | False |
| authorships[15].author.id | https://openalex.org/A5014348565 |
| authorships[15].author.orcid | https://orcid.org/0000-0002-4177-5668 |
| authorships[15].author.display_name | Soichiro Kiyono |
| authorships[15].author_position | middle |
| authorships[15].raw_author_name | Soichiro Kiyono |
| authorships[15].is_corresponding | False |
| authorships[16].author.id | https://openalex.org/A5083755934 |
| authorships[16].author.orcid | https://orcid.org/0000-0001-7821-6109 |
| authorships[16].author.display_name | Naoya Kanogawa |
| authorships[16].author_position | middle |
| authorships[16].raw_author_name | Naoya Kanogawa |
| authorships[16].is_corresponding | False |
| authorships[17].author.id | https://openalex.org/A5016770705 |
| authorships[17].author.orcid | https://orcid.org/0000-0002-1075-9876 |
| authorships[17].author.display_name | Takayuki Kondo |
| authorships[17].author_position | middle |
| authorships[17].raw_author_name | Takayuki Kondo |
| authorships[17].is_corresponding | False |
| authorships[18].author.id | https://openalex.org/A5079731833 |
| authorships[18].author.orcid | https://orcid.org/0009-0006-2767-172X |
| authorships[18].author.display_name | Eiichiro Suzuki |
| authorships[18].author_position | middle |
| authorships[18].raw_author_name | Eiichiro Suzuki |
| authorships[18].is_corresponding | False |
| authorships[19].author.id | https://openalex.org/A5010887566 |
| authorships[19].author.orcid | https://orcid.org/0000-0002-5095-8183 |
| authorships[19].author.display_name | Yoshihiko Ooka |
| authorships[19].author_position | middle |
| authorships[19].raw_author_name | Yoshihiko Ooka |
| authorships[19].is_corresponding | False |
| authorships[20].author.id | https://openalex.org/A5050720566 |
| authorships[20].author.orcid | https://orcid.org/0000-0002-7241-219X |
| authorships[20].author.display_name | Shingo Nakamoto |
| authorships[20].author_position | middle |
| authorships[20].raw_author_name | Shingo Nakamoto |
| authorships[20].is_corresponding | False |
| authorships[21].author.id | https://openalex.org/A5070639273 |
| authorships[21].author.orcid | https://orcid.org/0000-0002-8659-2873 |
| authorships[21].author.display_name | Yosuke Inaba |
| authorships[21].author_position | middle |
| authorships[21].raw_author_name | Yosuke Inaba |
| authorships[21].is_corresponding | False |
| authorships[22].author.id | https://openalex.org/A5022537134 |
| authorships[22].author.orcid | https://orcid.org/0000-0002-4050-2086 |
| authorships[22].author.display_name | Masafumi Ikeda |
| authorships[22].author_position | middle |
| authorships[22].raw_author_name | Masafumi Ikeda |
| authorships[22].is_corresponding | False |
| authorships[23].author.id | https://openalex.org/A5041387729 |
| authorships[23].author.orcid | https://orcid.org/0009-0001-1339-0461 |
| authorships[23].author.display_name | Shinichiro Okabe |
| authorships[23].author_position | middle |
| authorships[23].raw_author_name | Shinichiro Okabe |
| authorships[23].is_corresponding | False |
| authorships[24].author.id | https://openalex.org/A5073484252 |
| authorships[24].author.orcid | https://orcid.org/0000-0001-9600-7407 |
| authorships[24].author.display_name | Naoki Morimoto |
| authorships[24].author_position | middle |
| authorships[24].raw_author_name | Naoki Morimoto |
| authorships[24].is_corresponding | False |
| authorships[25].author.id | https://openalex.org/A5038459903 |
| authorships[25].author.orcid | https://orcid.org/0000-0001-9890-3635 |
| authorships[25].author.display_name | Yoshito Itoh |
| authorships[25].author_position | middle |
| authorships[25].raw_author_name | Yoshito Itoh |
| authorships[25].is_corresponding | False |
| authorships[26].author.id | https://openalex.org/A5066057806 |
| authorships[26].author.orcid | https://orcid.org/0009-0000-7415-6540 |
| authorships[26].author.display_name | Kazuyoshi Nakamura |
| authorships[26].author_position | middle |
| authorships[26].raw_author_name | Kazuyoshi Nakamura |
| authorships[26].is_corresponding | False |
| authorships[27].author.id | https://openalex.org/A5060921685 |
| authorships[27].author.orcid | https://orcid.org/0009-0008-2208-9882 |
| authorships[27].author.display_name | Kenji Ito |
| authorships[27].author_position | middle |
| authorships[27].raw_author_name | Kenji Ito |
| authorships[27].is_corresponding | False |
| authorships[28].author.id | https://openalex.org/A5041376226 |
| authorships[28].author.orcid | https://orcid.org/0009-0002-2331-0303 |
| authorships[28].author.display_name | Ryosaku Azemoto |
| authorships[28].author_position | middle |
| authorships[28].raw_author_name | Ryosaku Azemoto |
| authorships[28].is_corresponding | False |
| authorships[29].author.id | https://openalex.org/A5080709934 |
| authorships[29].author.orcid | https://orcid.org/0000-0003-3374-7111 |
| authorships[29].author.display_name | Masanori Atsukawa |
| authorships[29].author_position | middle |
| authorships[29].raw_author_name | Masanori Atsukawa |
| authorships[29].is_corresponding | False |
| authorships[30].author.id | https://openalex.org/A5051447472 |
| authorships[30].author.orcid | https://orcid.org/0000-0003-0475-2819 |
| authorships[30].author.display_name | Ei Itobayashi |
| authorships[30].author_position | middle |
| authorships[30].raw_author_name | Ei Itobayashi |
| authorships[30].is_corresponding | False |
| authorships[31].author.id | https://openalex.org/A5041139736 |
| authorships[31].author.orcid | https://orcid.org/0000-0001-5812-2818 |
| authorships[31].author.display_name | Naoya Kato |
| authorships[31].author_position | last |
| authorships[31].raw_author_name | Naoya Kato |
| authorships[31].is_corresponding | False |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1158/1078-0432.24710897.v1 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Table S5 from A Prospective Study Exploring the Safety and Efficacy of Lenvatinib for Patients with Advanced Hepatocellular Carcinoma and High Tumor Burden: The LAUNCH Study |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10073 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.996999979019165 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2721 |
| primary_topic.subfield.display_name | Hepatology |
| primary_topic.display_name | Hepatocellular Carcinoma Treatment and Prognosis |
| related_works | https://openalex.org/W3122656440, https://openalex.org/W3025508748, https://openalex.org/W3008495314, https://openalex.org/W4205110801, https://openalex.org/W4310710346, https://openalex.org/W4242832232, https://openalex.org/W2984374861, https://openalex.org/W2283802670, https://openalex.org/W4390953075, https://openalex.org/W4220717070 |
| cited_by_count | 0 |
| locations_count | 2 |
| best_oa_location.id | doi:10.1158/1078-0432.24710897.v1 |
| best_oa_location.is_oa | True |
| best_oa_location.source | |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | |
| best_oa_location.version | acceptedVersion |
| best_oa_location.raw_type | posted-content |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | |
| best_oa_location.landing_page_url | https://doi.org/10.1158/1078-0432.24710897.v1 |
| primary_location.id | doi:10.1158/1078-0432.24710897.v1 |
| primary_location.is_oa | True |
| primary_location.source | |
| primary_location.license | cc-by |
| primary_location.pdf_url | |
| primary_location.version | acceptedVersion |
| primary_location.raw_type | posted-content |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | False |
| primary_location.raw_source_name | |
| primary_location.landing_page_url | https://doi.org/10.1158/1078-0432.24710897.v1 |
| publication_date | 2023-12-01 |
| publication_year | 2023 |
| referenced_works_count | 0 |
| abstract_inverted_index.by | 10 |
| abstract_inverted_index.to | 3 |
| abstract_inverted_index.1.1 | 8 |
| abstract_inverted_index.and | 6 |
| abstract_inverted_index.both | 4 |
| abstract_inverted_index.RECIST | 7 |
| abstract_inverted_index.central | 11 |
| abstract_inverted_index.mRECIST | 5 |
| abstract_inverted_index.according | 2 |
| abstract_inverted_index.(evaluation | 9 |
| abstract_inverted_index.assessments | 1 |
| abstract_inverted_index.review)</p> | 12 |
| abstract_inverted_index.<p>Radiological | 0 |
| cited_by_percentile_year | |
| countries_distinct_count | 0 |
| institutions_distinct_count | 32 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.6000000238418579 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.35684775 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |